Showing posts with label Partnerships in Asia. Show all posts
Showing posts with label Partnerships in Asia. Show all posts

Monday, December 7, 2009

A Look Back at Partnerships in Clinical Trials Asia Pacific!

Last week, we held the First Annual Partnerships in Clinical Trials Asia Pacific. At this meeting, we heard from many of the professionals who work closely with the clinical trails in the region, as well as where the expect to see the region to go within the next few years. See some of the sessions here:

Focus on China

Tailoring Outsourcing Strategies for the Asia-Pacific Region – Functional Insourcing

The Sponsor-Site Relationship: Optimizing the CRO Partnership

How partnering with Japan CROs Can Benefit the Global & Asian Drug Development

Regional Regulatory Briefings – What It Takes to Get Your Regional Clinical Trial Going

Accelerating Patient Recruitment and Retention in Clinical Trials


Share this article with your social network, just click below to share now!


Friday, September 25, 2009

Partnerships APAC looks at clinical trials in the Asia region

Due to the rapid growth and increasing interest in the Asia Pacific clinical trial market, we are happy to announce that in a few short months, we will debut Partnerships in Clinical Trials Asia Pacific – our first program specifically tailored for conducting clinical trials in this region.

Partnerships APAC represents a time and cost-effective way to evaluate CROs without visiting each region one by one. From local, regional specialists to well-known global partners – this is your chance to figure out which partners match up with your trials’ needs. Our diverse speaking faculty represent experts from most of the region’s key areas for clinical development, saving your time and travel budget with just ONE meeting for the complete picture of conducting clinical trials in the APAC region.

In addition to key industry speakers from India, China, Japan, Singapore, Vietnam and more, the event also features US counterparts talking about proven strategies that they’ve implemented in conducting trials overseas. Combine this with the local regulatory insight you will gain and you’re not just buying a pass to a conference – you’re investing in future clinical trials by preventing delays and determining how to best navigate in this region.


Share this article with your social network, just click below to share now!